In the last trading session, 1.03 million shares of the CureVac N.V (NASDAQ:CVAC) were traded, and its beta was 2.45. Most recently the company’s share price was $4.35, and it changed around $0.26 or 6.36% from the last close, which brings the market valuation of the company to $979.43M. CVAC currently trades at a discount to its 52-week high of $5.28, offering almost -21.38% off that amount. The share price’s 52-week low was $2.37, which indicates that the current value has risen by an impressive 45.52% since then. We note from CureVac N.V’s average daily trading volume that its 10-day average is 0.86 million shares, with the 3-month average coming to 643.30K.
CureVac N.V stock received a consensus recommendation rating of Buy, based on a mean score of 2.00. If we narrow it down even further, the data shows that 0 out of 6 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 2 recommended CVAC as a Hold, whereas 2 deemed it a Buy, and 1 rated it as Underweight.
CureVac N.V (NASDAQ:CVAC) trade information
Instantly CVAC has showed a green trend with a performance of 6.36% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 4.45 on recent trading dayincreased the stock’s daily price by 2.25%. The company’s shares are currently up 27.57% year-to-date, but still up 12.40% over the last five days. On the other hand, CureVac N.V (NASDAQ:CVAC) is 34.67% up in the 30-day period. We can see from the shorts that 4.99 million shares have been sold at a short interest cover period of 7.87 day(s).
The consensus price target as assigned by Wall Street analysts is $29, which translates to bulls needing to increase their stock price by 85.0% from its current value. Analyst projections state that CVAC is forecast to be at a low of $21 and a high of $37.
CVAC Dividends
CureVac N.V’s next quarterly earnings report is expected to be released on 2025-May-19.
CureVac N.V (NASDAQ:CVAC)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 57.44% of CureVac N.V shares, and 4.62% of them are in the hands of institutional investors. The stock currently has a share float of 10.85%. CureVac N.V stock is held by 127.0 institutions, with MILLENNIUM MANAGEMENT LLC being the largest institutional investor. By 2024-06-30, it held 1.2808% of the shares, which is about 2.87 million shares worth $9.77 million.
POINT72 ASSET MANAGEMENT, L.P., with 1.0801% or 2.42 million shares worth $8.24 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
iShares Trust-iShares Core MSCI EAFE ETF and iShares Trust-iShares Biotechnology ETF were the top two Mutual Funds as of Mar 31, 2025 . The former held 652.13 shares worth $2.84 million, making up 0.29% of all outstanding shares. On the other hand, iShares Trust-iShares Biotechnology ETF held roughly 598.13 shares worth around $2.6 million, which represents about 0.27% of the total shares outstanding.
